Stockreport

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Inovio Pharmaceuticals (INO) Investors with Significant Losses to Contact its Attorneys: Securities Fraud Class Action Filed

Inovio Pharmaceuticals, Inc.  (INO) 
NASDAQ:AMEX Investor Relations: ir.inovio.com/investors/default.aspx
PDF SAN FRANCISCO, March 16, 2020 (GLOBE NEWSWIRE) -- Hagens Berman urges investors in Inovio Pharmaceuticals, Inc. (NASDAQ: INO) who have suffered significant losses to s [Read more]